![Richard Marshall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 22 417 $ al 31/05/2026
Richard Marshall is Chief Executive Officer at Juvenescence Ltd. and Juvenescence Therapeutics Ltd. since 2023.
Since 2024, Dr. Marshall is an Independent Director at Serina Therapeutics, Inc. From 2019 to 2023, Dr. Marshall was SVP, Global Head-Respiratory & Immunology at AstraZeneca PLC.
From 2002 to 2018, Dr. Marshall was Vice President-Fibrosis Research & Development at GSK Plc.
Dr. Marshall completed undergraduate and doctorate degrees at University College London.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
0,08 % | 17/06/2026 | 12.183 ( 0,08 % ) | 22 417 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Juvenescence Ltd.
 Juvenescence Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Director Ejecutivo | 16/01/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2023 |
| GSK PLC | Corporate Officer/Principal | 01/01/2018 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juvenescence Ltd.
Juvenescence Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
